本页面由Tiger Trade Technology Pte. Ltd.提供服务

ESSA Pharma Inc.

0.2012
0.0000
成交量:- -
成交额:116.42万
市值:951.84万
市盈率:-0.35
高:0.2012
开:0.2012
低:0.2012
收:0.2012
52周最高:6.45
52周最低:0.1800
股本:4,730.84万
流通股本:2,607.40万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.5692
每股收益(LYR):-0.6446
净资产收益率:-21.25%
总资产收益率:-15.25%
市净率:0.09
市盈率(LYR):-0.31

数据加载中...

2025/10/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/09

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/10/09

重要事件披露

Form 8-K - Current report
2025/10/06

重要事件披露

Form 8-K - Current report
2025/10/03

重要事件披露

Form 8-K - Current report
2025/09/30

重要事件披露

Form 8-K - Current report
2025/09/24

重要事件披露

Form 8-K - Current report
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/25

重要事件披露

Form 8-K - Current report
2025/08/15

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/31

重要事件披露

Form 8-K - Current report
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/14

重要事件披露

Form 8-K - Current report
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]